A more recent version of this regulatory record is available. This version is kept only as a historical record. Please see the Record history section for link to the most recent version.



List details

Basic info

Status Opinion Adopted
Submitter Germany
Regulatory programme
  • Chemical registered under REACH
CLP Annex VI Index Number
  • 612-067-00-9


Harmonised classification at the time of the proposal
  • Acute Tox. 4*, H302
  • Acute Tox. 4*, H312
  • Skin Corr. 1B, H314
  • Skin Sens. 1, H317
  • Aquatic Chronic 3, H412
Proposed harmonised classification by the dossier submitter
  • Acute Tox. 4, H302
  • Skin Corr. 1B, H314
  • Eye Dam. 1, H318
  • Skin Sens. 1A, H317
Hazard classes open for commenting Acute toxicity Serious eye damage/eye irritation Skin sensitisation Hazardous to the aquatic environment

Intention timeline

Date of intention 2017-08-25
Expected date of submission 2017-10-31
Submitted for accordance check 2017-11-06
Final submission date 2018-08-30
Start of consultation 2018-10-08
Deadline for commenting 2018-12-07
Date of opinion 2019-06-13
Legal deadline for opinion adoption 2020-02-29


CLH report
Annexes to the CLH Report
Comments received
Public consultations - received attachments
RAC opinion
Background document external link [echa.europa.eu]

Related substances

By adding any of the following substances to your watchlist, you would be monitoring this regulatory record and all possible new regulatory records related to that substance.

Related regulatory records

Record history

The following timeline shows when we detected changes of this regulatory record (the date might slightly differ from the date of the actual change). Additions between versions are hightlighted in green color, red color shows data removed between versions.

Sept. 24, 2019
  • Proposed specific concentration limits by the dossier submitter: oral: ATE = 1030 mg/kg bw
This version
Sept. 6, 2019
  • Background document: https://echa.europa.eu/documents/10162/25fc5aeb-515b-639d-544a-d5e4a42cbd1a
  • Comments received: https://echa.europa.eu/documents/10162/21cecc1a-a630-405a-6b17-3eb6e6ad5973https://echa.europa.eu/documents/10162/d1b13856-7103-9b9c-9290-59970459de25
  • Date of opinion: 2019-06-142019-06-13
  • RAC opinion: https://echa.europa.eu/documents/10162/e0ea85e2-c62d-999e-6b76-6821423d1ed4
July 26, 2019
  • Date of opinion: 2019-06-14
  • Status: Opinion DevelopmentOpinion Adopted
April 4, 2019
  • Regulatory programme: Other substanceChemical registered under REACH
Dec. 20, 2018
  • Comments received: https://echa.europa.eu/documents/10162/21cecc1a-a630-405a-6b17-3eb6e6ad5973
  • Public consultations - received attachments: https://echa.europa.eu/documents/10162/3a9995d1-56c5-bb75-02b2-88eaa831bd14
  • Status: Public ConsultationOpinion Development
Oct. 16, 2018
  • Annexes to the CLH Report: https://echa.europa.eu/documents/10162/42adb754-c9c8-b3cf-07b3-99c48dda02ac
  • CLH report: https://echa.europa.eu/documents/10162/4552894f-149f-70f9-5e3a-32812572bc24
  • Deadline for commenting: 2018-12-07
  • Final submission date: 2018-08-30
  • Hazard classes open for commenting: Acute toxicity Serious eye damage/eye irritation Skin sensitisation Hazardous to the aquatic environment
  • Legal deadline for opinion adoption: 2020-02-29
  • Status: SubmittedPublic Consultation
  • Start of consultation: 2018-10-08
Add the related substance to your watchlist to monitor this regulatory record.